← Sunscreen

Chemical vs Mineral Sunscreens

Why chemical sunscreen ingredients raise safety concerns and how mineral alternatives differ

Most commercial sunscreens sold in the U.S. rely on chemical UV filters — synthetic compounds that absorb ultraviolet radiation. The most common chemical active ingredients include oxybenzone (benzophenone-3), octinoxate (octyl methoxycinnamate), avobenzone, homosalate, and octocrylene. Mineral sunscreens, by contrast, use zinc oxide and titanium dioxide — physical particles that sit on top of the skin and reflect or scatter UV rays.

The distinction matters because of what happens after you apply them.

Chemical Sunscreens Enter Your Bloodstream

In 2019, the FDA published a landmark randomized clinical trial in JAMA that changed the conversation around sunscreen safety [1]. Researchers applied four commercially available sunscreens (spray, lotion, and cream formulations) to 24 healthy volunteers under maximal use conditions — the way the label actually tells you to use them. Blood samples were taken over seven days.

The results were striking: all six chemical active ingredients tested — oxybenzone, octinoxate, octocrylene, homosalate, avobenzone, and ecamsule — exceeded the FDA's threshold of 0.5 ng/mL in plasma after just a single application. Some remained elevated for days. Oxybenzone reached plasma concentrations over 200 ng/mL, exceeding the safety threshold by more than 400 times.

A follow-up study in 2020 expanded the work with a larger cohort and confirmed the findings [2]. The FDA emphasized that exceeding the threshold doesn't necessarily mean these ingredients are unsafe — it means they require further toxicology testing that has never been done. The FDA's 2019 proposed rule reclassified these ingredients from "Generally Recognized as Safe and Effective" (GRASE) to requiring additional data. Only zinc oxide and titanium dioxide retained GRASE status.

Oxybenzone: The Worst Offender

Among chemical filters, oxybenzone deserves special attention. It is the most commonly used UV filter worldwide and the most studied for adverse effects. Research has identified it as an endocrine-disrupting compound — it can mimic estrogen, block testosterone, and interfere with thyroid hormones [5]. Studies have detected oxybenzone in breast milk, amniotic fluid, urine, and blood.

Beyond human health, oxybenzone causes measurable harm to marine ecosystems. A 2016 study published in Archives of Environmental Contamination and Toxicology demonstrated that oxybenzone is toxic to coral larvae at concentrations as low as 62 parts per trillion [3]. It induces coral bleaching, damages DNA, and disrupts the endocrine system of juvenile corals [4]. An estimated 14,000 tons of sunscreen wash into coral reefs annually.

Hawaii became the first U.S. state to ban the sale of sunscreens containing oxybenzone and octinoxate, effective January 1, 2021. Key West, Florida, the U.S. Virgin Islands, Palau, Aruba, and Bonaire have enacted similar restrictions.

What the FDA Actually Found

The 2019 FDA trial (Matta et al.) was a single-center, randomized study of 24 participants who applied one of four sunscreen formulations (two sprays, one lotion, one cream) to 75% of body surface area four times per day for four days [1]. Thirty blood samples were collected per participant over seven days. All four products produced systemic absorption above 0.5 ng/mL — the FDA's threshold for waiving additional nonclinical toxicology studies.

The 2020 follow-up expanded the cohort to 48 participants and tested six active ingredients across four formulations (lotion, aerosol spray, non-aerosol spray, and pump spray) [2]. Key findings:

  • Oxybenzone reached peak plasma concentrations exceeding 200 ng/mL
  • All six ingredients exceeded the 0.5 ng/mL threshold after a single application on day 1
  • Concentrations remained above threshold through day 7 (three days after last application) for most ingredients
  • Systemic absorption occurred regardless of formulation type

It is important to note that the FDA explicitly stated these results do not mean people should stop using sunscreen. Rather, they underscore that the safety of these ingredients was assumed, not proven, and that proper toxicology studies are now necessary.

Zinc oxide and titanium dioxide were not included in these absorption studies because they are inorganic minerals with particle sizes too large for systemic absorption. The FDA classified them as the only two GRASE sunscreen active ingredients in the United States.

Regarding endocrine disruption, a 2020 review in Current Dermatology Reports compiled evidence from in vitro and in vivo studies showing that oxybenzone, octinoxate, homosalate, and 4-methylbenzylidene camphor all demonstrate hormonal activity [5]. Oxybenzone has the strongest evidence base, with epidemiological studies associating urinary oxybenzone levels with altered reproductive hormone levels in men, earlier puberty in girls, and lower birth weight in newborns — though causation has not been definitively established in humans.

References

  1. Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical TrialMatta MK, Zusterzeel R, Pilli NR, et al.. JAMA, 2019. PubMed 30681057 →
  2. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical TrialMatta MK, Florian J, Zusterzeel R, et al.. JAMA, 2020. PubMed 31961417 →
  3. Toxicopathological Effects of the Sunscreen UV Filter, Oxybenzone (Benzophenone-3), on Coral Planulae and Cultured Primary Cells and Its Environmental Contamination in Hawaii and the U.S. Virgin IslandsDowns CA, Kramarsky-Winter E, Segal R, et al.. Archives of Environmental Contamination and Toxicology, 2016. PubMed 27060802 →
  4. The Effect of Oxybenzone on Planulae of the Scleractinian Coral Stylophora pistillataHe T, Tsui MMP, Tan CJ, et al.. Chemosphere, 2019. PubMed 29596476 →
  5. Sunscreen Products as Endocrine Disrupting ChemicalsSuh S, Pham C, Smith J, Mesinkovska NA. Current Dermatology Reports, 2020. PubMed 32049925 →

Weekly Research Digest

Get new topics and updated research delivered to your inbox.